Press release
UV Curable Adhesives Market Witnesses Surge in Demand Across Various Industries
Uveitis Treatment Market
Key Drivers of Market Growth
The demand for UV adhesives is escalating due to their strong bonding capabilities, short drying times, and lower volatile organic compounds (VOCs). These properties are becoming increasingly important as environmental concerns and stricter VOC emission regulations gain traction. Moreover, the growing awareness of the harmful effects of UV radiation on human skin is expected to further fuel the demand for UV adhesives.
In addition, the popularity of solar roofs and other environmentally friendly products is boosting the market for UV adhesives. The need for weather-resistant flexible packaging applications is also propelling market growth, as these adhesives are frequently used to laminate foils, sheets, and films for product packaging.
To Receive A PDF Sample Of The Report, Visit @https://www.emergenresearch.com/request-sample/3471
Market Constraints
Despite the positive outlook, the market faces challenges due to the easy availability of cost-effective and efficient alternative adhesives. Many low-cost substitutes for UV adhesives are readily available in the market, which hampers the growth of UV curable adhesives. Additionally, there is a lack of awareness about UV adhesives in developing countries, where they are relatively new and still in their early stages of market adoption.
Industry Insights
The market is categorized by end users, including medical, electrical and electronics, transportation, packaging, furniture, and other industries. The medical industry dominated the UV adhesives market in 2021 and is projected to grow at a compound annual growth rate (CAGR) of 11.2% from 2022 to 2027. UV adhesives are widely used in the manufacturing of medical devices such as catheters, syringes, and medical filters, which are essential for treating chronic illnesses like diabetes.
As the prevalence of diabetes continues to rise due to environmental, genetic, and insulin resistance factors, the demand for medical supplies such as syringes and filters has surged. Consequently, the production of these supplies has increased, driving the market expansion for UV adhesives in the medical sector.
Future Outlook
The UV Curable Adhesives market is poised for robust growth, supported by rapid urbanization and industrialization, significant expansion in the e-commerce industry, and extensive research and development (R&D) efforts. A noteworthy initiative in this regard is the collaboration between The Dow and Last Mile Education Fund, which launched a joint fund in January 2023 to support low-income students nearing the completion of their manufacturing and skilled trades programs.
To Get A Discount On The Latest Report, Visit @ https://www.emergenresearch.com/request-discount/3471
Uveitis Treatment Top Companies and Competitive Landscape
The market for uveitis treatments is very competitive, with major players focused on biologics, immunosuppressive drugs, and corticosteroids. Leading drug companies like Novartis, AbbVie, and Roche are at the top of their fields thanks to new treatments like biologic medicines and targeted therapies. Additionally, new biotech companies are creating new treatments to meet unmet needs, which helps the market grow.
Generics and biosimilars, which are cheaper options, are also in the market and compete with new drugs. Companies are putting money into research and development to make treatments work better and have fewer side effects. They also often work together with research institutions to come up with new products and get them on the market faster.
In March 2022, Bausch + Lomb and Clearside Biomedical launched XIPERE. It is the first U.S. FDA approved therapy for suprachoroidal use for treating macular edema associated with eye inflammation/uveitis.
Some of the key companies in the global Uveitis Treatment Market include:
AbbVie Inc.
Santen Pharmaceutical Co., Ltd.
Bausch Health Companies Inc.
Regeneron Pharmaceuticals Inc.
EyePoint Pharmaceuticals, Inc.
Novartis AG
Ocular Therapeutix, Inc.
Ophthotech Corporation
Pfizer Inc.
GlaxoSmithKline plc (GSK)
AstraZeneca
Bristol-Myers Squibb (BMS)
Browse Detailed Research Report @ https://www.emergenresearch.com/industry-report/uveitis-treatment-market
Uveitis Treatment Latest Industry Updates
In April 2022, Bausch + Lomb and Clearside Biomedical announced that the United States Food and Drug Administration (FDA) has approved XIPERE (triamcinolone acetonide). XIPERE is an injectable suspension administered through a suprachoroidal route to treat macular edema associated with uveitis.
In January 2023, Alimera Sciences Europe Limited has launched ILUVIEN in the Netherlands. ILUVIEN is used in the treatment of diabetic macular edema (DME) and non-infectious uveitis affecting the posterior segment (NIPU). The strategy behind the launch is geographic expansion, making ILUVIEN available for more physicians and patients in new markets.
Uveitis Treatment Market Segmentation Analysis
Treatment Outlook (Revenue, USD Million; 2020-2033)
Corticosteroids
Immunosuppressant
Monoclonal Antibodies
Cycloplegic Agents
Antibiotics
Antivirals
Antifungal
Analgesics
Disease Outlook (Revenue, USD Million; 2020-2033)
Anterior Uveitis
Posterior Uveitis
Intermediate Uveitis
Panuveitis
Cause Outlook (Revenue, USD Million; 2020-2033)
Infectious
Non-infectious
Distribution Channel Outlook (Revenue, USD Million; 2020-2033)
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Others
Regional Outlook (Revenue, USD Million; 2020-2033)
North America
United States
Canada
Mexico
Europe
Germany
France
United Kingdom
Italy
Spain
Benelux
Rest of Europe
Asia-Pacific
China
India
Japan
South Korea
Rest of Asia-Pacific
Latin America
Brazil
Rest of Latin America
Middle East and Africa
Saudi Arabia
UAE
South Africa
Turkey
Rest of MEA
Buy Now: @ https://www.emergenresearch.com/select-license/3471
Browse More Report By Emergen Research:
Uveitis Treatment Market Size @ https://www.emergenresearch.com/industry-report/uveitis-treatment-market/market-size
Uveitis Treatment Market Share @ https://www.emergenresearch.com/industry-report/uveitis-treatment-market/market-share
Uveitis Treatment Market Trends @ https://www.emergenresearch.com/industry-report/uveitis-treatment-market/market-trends
Uveitis Treatment Regional Market Demand @ https://www.emergenresearch.com/industry-report/uveitis-treatment-market/regional-market-demand
Uveitis Treatment Market Analysis @ https://www.emergenresearch.com/industry-report/uveitis-treatment-market/market-analysis
Contact Us:
Eric Lee
Corporate Sales Specialist
Emergen Research | Web: www.emergenresearch.com
Direct Line: +1 (604) 757-9756
E-mail: sales@emergenresearch.com
Visit for More Insights: https://www.emergenresearch.com/insights
Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyse consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release UV Curable Adhesives Market Witnesses Surge in Demand Across Various Industries here
News-ID: 3842222 • Views: …
More Releases from Emergen Research
Global Internet of Things (IoT) in Healthcare Market to Reach USD 299.05 Billion …
The global Internet of Things (IoT) in Healthcare Market was valued at USD 299.05 billion in 2023 and is expected to grow at a CAGR of 16.5% during the forecast period. This growth is fueled by the rising use of connected healthcare devices, increasing demand for early disease detection through remote monitoring, and growing adoption of artificial intelligence (AI) tools within IoT-based healthcare systems.
The market is also benefiting from the…
Global Stem Cell Therapy Market to Reach USD 49.2 Billion by 2034, Growing at 13 …
The global Stem Cell Therapy Market, valued at USD 13.7 billion in 2024, is projected to reach USD 49.2 billion by 2034, expanding at a compound annual growth rate (CAGR) of 13.6%. Growth is being fueled by the rising burden of chronic diseases, rapid progress in cell-based studies, and increasing investments in regenerative medicine and personalized healthcare solutions.
Stem cell therapies offer the ability to repair, replace, or restore damaged tissues…
Artificial Intelligence Strengthens Cybersecurity as Threats Grow More Sophistic …
The global Artificial Intelligence in cybersecurity market size was USD 23.8 Billion in 2023 and is expected to reach a market valuation of USD 29.44 billion by the end of 2024 registering a CAGR of 23.7% during the forecast period. The adoption of Artificial Intelligence (AI) in cybersecurity is rapidly gaining traction as organizations worldwide face increasingly complex and frequent cyber threats. By combining advanced technologies such as Machine Learning…
Global Regenerative Medicine Market to Reach USD 125.6 Billion by 2034, Growing …
The global regenerative medicine market, valued at USD 34.2 billion in 2024, is set to grow to USD 125.6 billion by 2034, expanding at a compound annual growth rate (CAGR) of 13.9%. Growth is being fueled by rising approvals of advanced therapies, strong demand for personalized treatments in cancer and orthopedics, and expanding cell and gene therapy manufacturing across major markets such as North America, Europe, and Asia.
Once seen as…
More Releases for Uveitis
Uveitis Market : An Overview Report
Introduction:
Uveitis is an inflammatory condition affecting the uvea, the middle layer of the eye. It can lead to vision impairment or even blindness if left untreated. Uveitis is categorized into different types, including anterior, intermediate, posterior, and panuveitis, depending on the part of the eye affected. The condition can be caused by infections, autoimmune diseases, or trauma. With increasing cases of autoimmune disorders and infectious diseases, the prevalence of uveitis…
Uveitis Treatment Market Size, Share | Trend 2030
Exclusive Report by Ameco Research: Uveitis Treatment Market Size Projected to Reach USD 2 Billion by 2030, Growing at 6% CAGR
Ameco Research is proud to announce the launch of its latest market research report, Uveitis Treatment Market. This comprehensive report provides in-depth analysis and insights into the current market trends and future projections in the Industry/Market Segment. Ameco Research has been at the forefront of providing quality market research…
Uveitis - Drug Pipeline Landscape, 2022
New York, Global Insight Services have recently published a report on Uveitis - Drug Pipeline Landscape. The pipeline landscape report provides analysis of pipeline products based on several stages of development ranging from Discovery to Pre-Registration.
Uveitis is an inflammation of the eye which damages the part of the eye called the uvea and affects other parts of the eyes which causes pain to the eyes. There are 4 types of…
Uveitis - Drug Pipeline Landscape, 2022
Global Insight Services have recently published a report on Uveitis - Drug Pipeline Landscape. The pipeline landscape report provides analysis of pipeline products based on several stages of development ranging from Discovery to Pre-Registration.
Uveitis is an inflammation of the eye which damages the part of the eye called the uvea and affects other parts of the eyes which causes pain to the eyes. There are 4 types of uveitis based…
Japan Industry Statistics of Uveitis Treatment
Global Uveitis Treatment Market: Overview
Uveitis, an autoimmune eye disease, is considered rare for just around 38 in 100,000 people are afflicted by it. Because of this, it is often overlooked. Patients afflicted by uveitis are often referred to an expert after much delay on account of less awareness about the eye malady. This delays timely diagnosis and results in irreversible damage to various ocular structures.
Read Report Overview: https://www.transparencymarketresearch.com/uveitis-treatment-market.html
As per Cochrane,…
Uveitis Treatment Market Analysis of Top industry Scenario
Global Uveitis Treatment Market report it provides a vital recent industry data which covers in general market situation along with future scenario for industry around the Globe. It also consists of major data along with forecasts of a global market along with clear presentation of diagrams (charts and tables).
According to a new report published by Allied Market Research, titled, "Uveitis Treatment Market by Drug Class (Anti-inflammatory, Antimicrobial Drugs, Immunotherapy &…
